EPR - the future of bio/pharmaceutical analysis online summit 2025 logo

The Future of

Bio/Pharmaceutical Analysis

Speakers

U.S. Pharmacopeia
Consultant (Uro-Oncology Franchise)
Ferring Pharmaceutical Inc, USA
Deputy General Manager (Analytical)
Innoxel Lifesciences Pvt Ltd
Head of QA GxP Compliance
Kedrion Biopharma, Inc.
Professor-of-the-Practice, Executive-in-Residence, SERC Director
University of Maryland
Analytical Specialist – External and Member of Nitrosamine Task Force
Novartis
Professor of Pharmaceutical Sciences
Texas A&M University
Solutions Product Manager
Bruker BioSpin GmbH & Co. KG
Global Product Manager – Automation & Robotics Solutions
Merck
Director at Flow Cytometry – Research & Regenerative Medicine Department
Iaso
United States Pharmacopoeia
Global Product Manager BioMonitoring – Pharma Innovation
Merck Life Science
Technical Specialist, LAL Division
Fujifilm Wako Chemicals USA
Chemistry Research Director
Merieux NutriSciences
Head of Microbiology, New Modalities and Parenteral Development
AstraZeneca
SME Testing Services
Lonza Walkersville, Inc.
Head of Process Analytical Technology, Data Engineering and Data Science
ReciBioPharm
Founding Expert Member and Nitrosamine Exchange Ambassador
Regulatory Compliance SME
Scientific Director
Symphogen
Senior lecturer in analytical chemistry
Liverpool John Moores University
Head-Toxicology, Safety Assessment Speakers
Syngene International Limited